*NEW* Free for members and $29 for nonmembers
New checkout process! Please view the video for assistance.
This interactive live webinar is part 14 of the Emerging and Evolving Biomarkers Series.
Description:
Join this webinar on FLT3-mutated AML, focusing on current therapy, diagnostic testing, and the use of PCR-NGS MRD assays in the clinical management of these patients.
Learning Objectives:
- Understand the use and limitations of the current companion diagnostic test for FLT3 inhibitors in clinical use today.
- Explain the role of different FLT3 inhibitors as incorporated into induction, consolidation, and maintenance therapy per NCCN guidelines.
- Discuss recent findings from randomized clinical trials incorporating high-sensitivity PCR-NGS MRD testing for FLT3-ITD mutations.
 |
 |
|---|---|
|
Speaker:
Mark Levis, MD, PhD John Hopkins Medicine
|
Moderator:
Jennifer Bynum, MD |
Duration: 1 Hour
Live webinar: September 28, 2023
How to Register:
- Click the "Register Now" Button
- Log in using your AMP credentials. If you do not have an AMP account, Create a FREE account.
- Complete the checkout process, Free for members and $29 for nonmembers
- Click on "My Courses" and complete the registration for the live webinar
- Complete the "Demographic questionnaire for Emerging and Evolving Biomarkers Series" before the webinar date. You will only need to do this once for the entire series.
Continuing Education Credit Information
Continuing Education Credit is no longer available.
Note: Join the AMP Family for discounted access to the most current educational resources!
All sales are final. No refunds will be issued.
No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentation.
